VITALE, Candida

VITALE, Candida  

BIOTECNOLOGIE MOLECOLARI E SCIENZE PER LA SALUTE  

Mostra records
Risultati 1 - 20 di 82 (tempo di esecuzione: 0.053 secondi).
Titolo Data di pubblicazione Autore(i) File
Abstract 2072: Selinexor in combination with chemotherapy or idelalisib elicits a synergistic cytotoxic effect in primary CLL cells 2019 Todaro Maria, Griggio Valentina, Salvetti Chiara, Riganti Chiara, Landesman Yosef, Boccadoro Mario, Vitale Candida, Coscia Marta
Accelerated activity of the mevalonate pathway supports the immune escape and multidrug-resistance phenotype of IGHV unmutated chronic lymphocytic leukemia cells 2011 M Coscia; M Rigoni; C Riganti; I Campia; C Vitale; V Griggio; S Peola; B Castella; F Pantaleoni; P Sciancalepore; D Drandi; P Omedè; M Ladetto; A Bosia; M Boccadoro; M Massaia
Bendamustine and alemtuzumab (BEN CAM) combination in relapsed and refractory chronic lymphocytic leukaemia (CLL): interim report of the italian trial 2011 A Tedeschi; M Coscia; D Rossi; F Ricci; G D'Arena; E Orlandi; V Belsito Petrizzi; L Scarfò; C Vitale; E Vismara; G Gaidano; E Morra; M Massaia; M Montillo
BENDAMUSTINE AND ALEMTUZUMAB (BEN CAM) COMBINATION IN RELAPSED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL): PHASE I SAFETY PROFILE RESULTS OF THE ITALIAN TRIAL 2010 A Tedeschi ;M Coscia ;D Rossi ;E Vismara ;F Ricci ;C Vitale ;E Morra ;G Gaidano ;M Massaia ;M Montillo
BENDAMUSTINE AND ALEMTUZUMAB (BEN CAM) COMBINATION IN RELAPSED AND REFRACTORY CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL): PRELIMINARY REPORT OF THE ITALIAN TRIAL 2011 Tedeschi, A; Coscia, M; Rossi, D; Ricci, F; D'Arena, G; Orlandi, E; Petrizzi, Vb; Scarfo, L; Vitale, C; Vismara, E; Gaidano, G; Morra, E; Massaia, M; Montillo, M
Bendamustine and Alemtuzumab combination in relapsed and refractory chronic lymphocytic leukemia: interim report of the italian trial 2011 A Tedeschi; M Coscia; D Rossi; F Ricci; G D'Arena; E Orlandi; V Belsito Petrizzi; L Scarfò; C Vitale; E Vismara; G Gaidano; E Morra; M Massaia; M Montillo
Bleeding diathesis associated with acquired von Willebrand Syndrome in three patients with chronic lymphocytic leukemia 2014 Candida Vitale; Mona Lisa Alattar; Maria Ciccone; Mahmoud R Gaballa; Xavier C Badoux; George Manoukian; Michael J Keating; Michael H Kroll; Alessandra Ferrajoli
CD200 INCLUDED IN A 4-MARKER MODIFIED MATUTES SCORE PROVIDES OPTIMAL SENSITIVITYAND SPECIFICITY FOR THE DIAGNOSIS OF CHRONIC LYMPHOCYTIC LEUKEMIA 2018 D'Arena, G; Vitale, C; Rossi, G; Coscia, M; Omede, P; D'Auria, F; Statuto, T; Valvano, L; Ciolli, S; Gilestro, M; Molica, S; Bellesi, S; Topini, G; Panichi, V; Autore, F; Innocenti, I; Musto, P; Deaglio, S; Laurenti, L; Del Vecchio, L
Centralized Biobanking Supports Hematology Clinical Trials: the new challenge of the University of Torino 2019 Gian Maria Zaccaria, Daniela Drandi, Simona Caltagirone, Martina Ferrante, Marco Ghislieri, Daniela Barbero, Marina Ruggeri, Barbara Mantoan, Elisa Genuardi, Daniela Oddolo, Giuseppe Lia, Valentina Griggio, Pierpaola Fenoglio, Mattia D’Agostino, Candida Vitale, Marta Coscia, Benedetto Bruno, Stefania Oliva, Paola Omedè, Alessandra Larocca, Simone Ferrero, Mario Boccadoro
Changes in lymphocyte subsets, angiogenic factors and plasma cytokines in patients with chronic lymphocytic leukemia during treatment with Ofatumumab and Lenalidomide 2015 Vitale C, ten Hacken E, Gao H, Keating MJ, O’Brien S, Wierda WG, Falchi L, Reuben J, Burger JA, Calin G, Ferrajoli A
Correlation Between Clinical Responses and Immune Characteristics in Patients with Relapsed CLL Treated with Ofatumumab and Lenalidomide 2015 Vitale C, Falchi L, ten Hacken E, Gao H, Shaim H, Van Roosbroeck K, Calin G, O'Brien S, Faderl S, Wang X, Wierda WG, Rezvani K, Reuben JM, Burger JA, Keating M, Ferrajoli A
The CXCR4 downstream signaling pathways in chronic lymphocytic leukemia: a target to reverse microenvironment protection 2016 Vitale C, Griggio V, Todaro M, Riganti C, Salaroglio IC, Salvetti C, Rigoni M, Foglietta M, Castella B, Boccadoro M, Massaia M, Coscia M
Differential Effects of Microenvironmental Elements On Tumor Cells Survival in Chronic Lymphocytic Leukemia Patient Subsets with Good or Poor Prognosis 2009 Marta Coscia; Francesca Pantaleoni; Chiara Riganti; Micol Rigoni; Candida Vitale; Silvia Peola; Daniela Drandi; Marco Ladetto; Amalia Bosia; Mario Boccadoro; Massimo Massaia
Early Results of a Phase II Study of Ofatumumab As Front-Line Treatment in Elderly, Unfit Patients with Chronic Lymphocytic Leukemia (CLL) 2014 Maria Ciccone; Candida Vitale; Christina Hinojosa; Michael J Keating; Naveen Pemmaraju; Susan O'Brien; Jan A. Burger; Deborah A. Thomas; Hagop M. Kantarjian; Paolo Strati; William G. Wierda; Alessandra Ferrajoli
EVALUATION OF ACCURACY OF "CLLFLOW SCORE" BY AN ESTERNAL VALIDATION MULTICENTER STUDY 2018 D'Arena, G; Vitale, C; Coscia, M; D'Auria, F; Statuto, T; Valvano, L; Bellesi, S; Topini, G; Panichi, V; Corrente, F; Innocenti, I; Musto, P; Laurenti, L
Evaluation of the cytotoxic effect of selinexor in combination with chemotherapy or idelalisib towards primary CLL cells 2020 Vitale C, Todaro M, Griggio V, Salvetti C, Riganti C, Landesman Y, Boccadoro M, Coscia M.
Final Report of Bendamustine and Alemtuzumab (BEN CAM) Combination in Relapsed and Refractory Chronic Lymphocytic Leukemia 2012 Alessandra Tedeschi; Davide Rossi; Marta Coscia; Eleonora Vismara; Valeria Belsito Petrizzi; Ester Orlandi; Nicola Cascavilla; Lydia Scarfò; Marina Motta; Candida Vitale; Francesca Ricci; Lorenzo De Paoli; Alfonso Maria D'Arco; Andrea Gallamini; Gianluca Gaidano; Enrica Morra; Massimo Massaia; Marco Montillo
Front-Line Treatment with Ofatumumab for Older Unfit Patients with Chronic Lymphocytic Leukemia 2015 Vitale C, Ciccone M, Hinojosa C, Keating MJ, Pemmaraju N, O'Brien S, Wierda WG, Thomas D, Borthakur G, Ohanian M, Burger JA, Ferrajoli A
Front‐line Treatment with Ofatumumab in Elderly Unfit Patients with CLL 2015 Vitale C, Ciccone M, Hinojosa C, Keating MJ, Pemmaraju N, O'Brien S, Wierda WG, Thomas D, Borthakur G, Ohanian M, Burger JA, Ferrajoli A
HIF-1 alpha Upregulation in TP53 Disrupted Chronic Lymphocytic Leukemia Cells and Its Potential Role As a Therapeutic Target 2016 Griggio, V; Vitale, C; Todaro, M; Riganti, C; Kopecka, J; Dal Bo, M; Rossi, D; Pozzato, G; Marchetti, M; Ruggeri, M; Omede, P; Laurenti, L; Del Poeta, G; Mauro, Fr; Gattei, V; Gaidano, G; Foa, R; Massaia, M; Boccadoro, M; Coscia, M